Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the

Farhoud Faraji1, Yanli Pang, Renard C Walker

  • 1Metastasis Susceptibility Section, Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

Plos Genetics
|October 3, 2012
PubMed

Insights

Cadherin-1 (Cadm1) suppresses cancer metastasis by enhancing immune surveillance, not by altering tumor cell growth or invasion. This gene requires T cell immunity to function, revealing a link between heritable factors and the immune system in metastasis.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Metastasis involves tumor cell-intrinsic traits and host factors, including immune responses.
  • Germline polymorphisms can influence cancer metastasis via cell-autonomous mechanisms.
  • The interaction between metastasis susceptibility genes and the tumor microenvironment is not fully understood.

Purpose of the Study:

  • To identify novel genes that modify cancer metastasis.
  • To investigate the mechanisms by which metastasis susceptibility genes interact with the host.
  • To explore the role of Cadherin-1 (Cadm1) in metastasis.

Main Methods:

  • A complex genetic screen was used to identify metastasis modifiers.
  • Experiments were conducted in mice with varying immune statuses (e.g., T cell deficient).
  • Tumor cell proliferation, invasion, and metastasis were assessed, along with CD8(+) T cell activity.

Main Results:

  • Cadm1 was identified as a novel suppressor of metastasis, independent of primary tumor growth.
  • Cadm1 did not affect tumor cell-autonomous properties like proliferation or invasion.
  • Cadm1's metastasis-suppressing function was dependent on T cell-mediated immunity and was lost in T cell-deficient mice.

Conclusions:

  • Cadm1 suppresses metastasis by sensitizing tumor cells to immune surveillance.
  • This study reveals a novel mechanism where a heritable metastasis susceptibility gene engages non-autonomous, immune-related factors.
  • Cadm1 represents a new target for understanding and potentially treating cancer metastasis through immune modulation.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...